Related Experiment Video
Updated: Jul 18, 2026
09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Pattern of thyroid autoimmunity in type 1 and type 2 diabetics
Tayyaba Yasmin1, Farkhanda Ghafoor, Tahir Malik
1Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|November 28, 2006
Summary
Thyroid autoimmunity is more prevalent in type 1 diabetes patients compared to type 2. This study found higher anti-thyroid peroxidase (anti-TPO) antibody levels in type 1 diabetics, indicating a stronger autoimmune link.
Area of Science:
- Endocrinology
- Immunology
- Diabetology
Background:
- Thyroid autoimmunity is a common comorbidity in diabetes mellitus.
- Understanding the prevalence and correlation of thyroid autoimmunity in different diabetes types is crucial for patient management.
Purpose of the Study:
- To assess thyroid autoimmunity levels in euthyroid patients with type 1 and type 2 diabetes.
- To correlate these autoimmunity levels with the specific diabetes pattern.
Main Methods:
- A cross-sectional analytical study was conducted.
- Blood samples from 163 subjects (type 1 diabetics, type 2 diabetics, and non-diabetic controls) were analyzed for thyroid profile (FT4, TSH, anti-TPO).
Main Results:
- Elevated anti-thyroid peroxidase (anti-TPO) antibodies were found in 61% of type 1 diabetics and 42.3% of type 2 diabetics, versus 12% in controls.
- Type 1 diabetics showed significantly higher TSH and anti-TPO antibodies compared to controls.
- Type 2 diabetics had moderately low TSH but higher anti-TPO antibodies and blood sugar levels (BSF) than controls.
Conclusions:
- Thyroid autoimmune processes are more strongly correlated with type 1 diabetes than type 2 diabetes.
- The findings suggest a significant link between thyroid autoimmunity and type 1 diabetes.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...